Multimorbidity in psoriasis as a risk factor for psoriatic arthritis: a population-based study
https://www.coltonconsortium.org/publications/multimorbidity-in-psoriasis-as-a-risk-factor-for-psoriatic-arthritis-a-population-based-study/
Archives: “Archives”
Showing 11 - 17 of 17 posts
Racial and ethnic determinants of psoriatic arthritis phenotypes and disease activity
https://www.coltonconsortium.org/publications/racial-and-ethnic-determinants-of-psoriatic-arthritis-phenotypes-and-disease-activity/
Diabetes mellitus—progress and opportunities in the evolving epidemic
https://www.coltonconsortium.org/publications/diabetes-mellitus-progress-and-opportunities-in-the-evolving-epidemic/
Differences in disease characteristics and treatment exposures between paediatric and adult-onset inflammatory bowel disease using a registry-based cohort
https://www.coltonconsortium.org/publications/differences-in-disease-characteristics-and-treatment-exposures-between-paediatric-and-adult-onset-inflammatory-bowel-disease-using-a-registry-based-cohort/
Clinical characteristics and outcomes of polyarteritis nodosa: an international study
https://www.coltonconsortium.org/publications/clinical-characteristics-and-outcomes-of-polyarteritis-nodosa-an-international-study/
Colton Consortium Sponsors 2025 FASEB Autoimmunity Conference
https://www.coltonconsortium.org/news/colton-consortium-sponsors-2025-faseb-autoimmunity-conference/The Colton Consortium sponsored the 2025 FASEB Autoimmunity Conference in Niagara Falls, a leading international forum dedicated to advancing autoimmune research and fostering collaboration among scientists and clinicians worldwide.
TAU Colton Center’s 2024 Grant Recipients Tackle Autoimmune Disease Across Nine Interdisciplinary Projects
https://www.coltonconsortium.org/news/tau-colton-centers-2024-grant-recipients-tackle-autoimmune-disease-across-nine-interdisciplinary-projects/Tel Aviv University's Colton Center has awarded nine interdisciplinary research grants in 2024, funding projects that explore autoimmune disease from organ-on-a-chip platforms to the role of stress and psychological factors in disease flare-ups.